April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 10, 2025

Medical Oddities: Chewing Gum to Fight Flu & Herpes

Gum that fights viruses, tea that tames tumors, and grip strength that beats your DNA—science is getting creative (and tasty) this week.

Conexiant

April 01, 2025

FDA Approves Freeze-Dried Jynneos Vaccine

Bavarian Nordic’s freeze-dried Jynneos vaccine offers logistical advantages over the liquid-frozen version, supporting long-term U.S. stockpiling and public health preparedness.

Conexiant

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 28, 2025

FDA Clears First OTC Multi-STI Test

The diagnostic test for chlamydia, gonorrhea, and trichomoniasis offers 30-minute results.

Conexiant

March 25, 2025

HPV May Double Coronary Artery Disease Risk

"Our study shows that clearly there is an association of some kind between HPV and cardiovascular disease."

Conexiant

March 25, 2025

New Oral Antibiotic Targets Uncomplicated UTIs

FDA approves gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urinary tract infections in females aged 12 and older, based on phase III trial results.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant